Skip to main content

Table 3 Statistically significant differences between healthy and RBT subjects

From: Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy

Molecule

Coupling

F2–F1 (ppm)

Control mean volume/Cr

RBT mean volume/Cr

% Diff between mean and RBT

Effect size

Glx-1

-CH2- CH(NH3+)

2.09–3.75

0.112 ± 0.009

0.147 ± 0.017

31 ± 18

3.11

Glx-3

 

2.07–3.73

0.022 ± 0.002

0.029 ± 0.004

32 ± 21

2.70

Glx-4

 

2.14–3.74

0.031 ± 0.002

0.042 ± 0.007

35 ± 24

2.88

Glx-6

 

2.45–2.01

0.018 ± 0.001

0.041 ± 0.011

77 ± 6

6.28

tCho

(CH3)3-N + −CH2-CH2-OH

4.05–4.05

0.250 ± 0.071

0.413 ± 0.051

65 ± 36

3.54

Fucose region and Thr

-CH(OH)-CH3 CH3-CH

(F2: 4.0–4.5, F1: 1.1–1.7)

0.022 ± 0.007

0.036 + 0.011

64 ± 61

2.64

Phe

-CH-(aromatic)-

7.33–7.33

0.024 ± 0.005

0.035 ± 0.008

46 ± 40

2.08

  1. Cross peak volumes were calculated relative to creatine. % Diff is the difference of the control and RBT means divided by the control mean ± the standard deviation. In bold are the proton groups that give rise to the crosspeak chemical shifts indicated in the third column.
  2. Abbreviations: Glx, crosspeaks of glutamate + glutamine; Phe, phenylalanine; RBT, repetitive brain trauma; tCho, total choline; Thr, threonine.